Open label, Multicentric, Comparative, RandomizedClinical Study to Evaluate the Safety and Efficacy ofOral administration of Tep-ADÃ?Â® (probioticLactobacillus salivarius) in Indian Children having byModerate and Severe Atopic Dermatitis.

Inzpera Healthsciences Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Male or female children between 0-11 years of age (both inclusive)
•Suffering from moderate or severe atopic dermatitis.
•Children and parents / guardians who agree to comply with study requirement and schedule.
•Parents or legal guardians willing to sign written informed consent form for the child and child
•willing to sign assent form for participation (if old enough to understand his /her participation

•1. Use of analgesics within <12 hours prior to the study start or/and inability to cancel them during
•2. Use of antibiotics within <48 hours prior to the study start or/and inability to cancel them during
•3. Subjects with any other chronic illness such as acute asthma, heart blocks, any congenital
•4. Subjects with chronic and infectious diseases.
•5. Subjects with hypersensitivity to any components contained in the probiotic sachets.
•6. Inability to keep return appointments.
•7. Participated in any clinical investigation in the last 30 days.
•8. Not found suitable as per discretion of investigator

发起方